Clinical trial
PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
NCT00380406 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00380406 |
|---|---|
| Title | PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial |
| Official title | PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial: A Randomized Controlled Trial of Gonadotropin Releasing Hormone Agonist (GnRHa) for Fertility Preservation in Oncology Patients |
| Acronym | PROOF |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Collaborators | University of Ottawa Queen's University Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fertility Preservation, Cancer |
| Intervention type | Drug |
| Interventions | Leuprolide acetate |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Sep 26, 2006 |
| Last update posted | Apr 5, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: